Table 5 Haematological toxicity
From: Concurrent chemoradiotherapy in adjuvant treatment of breast cancer
Toxicity | Group A No (%) | Group B No (%) | p value |
|---|---|---|---|
Anemia | Â | Â | Â |
Grade I | 35 (32.4%) | 25 (19.2%) | 0.009 |
Grade II | 13 (12%) | 7 (5.4%) | Â |
Grade III | 2 (1.9%) | 1 (1.3%) | Â |
Grade IV | 0 | Â | Â |
Neutropenia | Â | Â | Â |
Grade I | 13 (12%) | 15 (11.5%) | 0.4 |
Grade II | 27 (25%) | 26 (20%) | Â |
Grade III | 8 (7.4%) | 8 (6.2%) | Â |
Grade IV | 2 (1.9%) | 0 | Â |
Thrombopenia | Â | Â | Â |
Grade I | 2 (1.9%) | 2 (1.5%) | 0.341 |
Grade II | 2 (1.9%) | 0 | Â |
Grade III | 1 (0.9%) | 0 | Â |
Grade IV | 0 | 1 (0.8%) | Â |